MUFG Americas’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
6CM
AG
MP
MUFG Americas's LRMR Position: Q1 2018 in Review
MUFG Americas sold out of Larimar Therapeutics (LRMR) in Q1 2018, closing a stake of 41 shares — an estimated $2K sold.
MUFG Americas first reported a position in LRMR in Q1 2016 and held it in 4 quarters. The position peaked at $11K in Q1 2016. 61 funds tracked by Wall St. Rank hold LRMR as of Q1 2018.
- MUFG Americas reported no remaining Larimar Therapeutics position as of Q1 2018 after selling out during the quarter.
- MUFG Americas sold 41 Larimar Therapeutics shares in Q1 2018, an estimated $2K.
- MUFG Americas first reported a position in Larimar Therapeutics in Q1 2016 and held it in 4 quarters.
- MUFG Americas's Larimar Therapeutics position peaked at $11K in Q1 2016.
- 61 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2018.
Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.